News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InfaCare To Present At Wells Fargo Healthcare Forum


10/19/2005 5:12:49 PM

NEPTUNE, N.J., Feb. 23 /PRNewswire/ -- InfaCare Pharmaceutical Corporation announced today that John R. Post, InfaCare's President and CEO, is scheduled to present at the upcoming Wells Fargo Healthcare Conference on Wednesday, March 2, 2005 at 10:00am. This conference is an opportunity for a broad range of biomedical companies to meet with healthcare-focused institutional investors over several days, from March 1-2, at the St. Regis Hotel in New York City.

For those unable to attend the conference in person, it is also being made available via webcast. The audio portion of InfaCare's presentation will be broadcast live and can be accessed at http://www.wallstreetwebcasting.com/webcast/wfc/infacare.

About InfaCare Pharmaceutical Corporation:

InfaCare is a privately held, specialty pharmaceutical company focused on the neonatal and pediatric markets. The company is currently developing Stanate(R) for the treatment of hyperbilirubinemia, the cause of jaundice and potential neurological damage, in neonates. InfaCare was founded in 2001 by Dr. Robert A. Vukovich, who is also Founder and former CEO of Roberts Pharmaceutical Corporation, and Founder and CEO of WellSpring Pharmaceutical Corporation.

InfaCare Pharmaceutical Corporation

CONTACT: Nancy Bracken, InfaCare Pharmaceutical Corporation,+1-732-938-5885, Fax: +1-732-751-9328


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES